PMC Articles for MedGen (Select 1612317) - PMC

Links from MedGen

Items: 1 to 20 of 148

<< First< Prev

Page of 8

Select item 108358741.

A reliable transcriptomic risk-score applicable to formalin-fixed paraffin-embedded biopsies improves outcome prediction in localized prostate cancer

Michael Rade, Markus Kreuz, Angelika Borkowetz, Ulrich Sommer, Conny Blumert, Susanne Füssel, Catharina Bertram, Dennis Löffler, Dominik J. Otto, Livia A. Wöller, Carolin Schimmelpfennig, Ulrike Köhl, Ann-Cathrin Gottschling, Pia Hönscheid, Gustavo B. Baretton, Manfred Wirth, Christian Thomas, Friedemann Horn, Kristin Reiche

Mol Med. 2024; 30: 19. Published online 2024 Feb 1. doi: 10.1186/s10020-024-00789-9

PMCID:: PMC10835874

Article PDF–1.7M

Select item 102285922.

Molecular hallmarks of multiparametric MRI visibility in prostate cancer

Kathleen E. Houlahan, Amirali Salmasi, Taylor Y. Sadun, Aydin Pooli, Ely R. Felker, Julie Livingstone, Vincent Huang, Steven S. Raman, Preeti Ahuja, Anthony E. Sisk, Jr, Paul C. Boutros, Robert E. Reiter

Eur Urol. Author manuscript; available in PMC 2023 May 30.

Published in final edited form as: Eur Urol. 2019 Jul; 76(1): 18–23. Published online 2019 Jan 24. doi: 10.1016/j.eururo.2018.12.036

PMCID:: PMC10228592

Article PDF–939K

Select item 100905533.

ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer

Song Yi Bae, Hannah E. Bergom, Abderrahman Day, Joseph T. Greene, Zoi E. Sychev, Gabrianne Larson, Eva Corey, Stephen R. Plymate, Tanya S. Freedman, Justin H. Hwang, Justin M. Drake

Front Endocrinol (Lausanne) 2023; 14: 1093332. Published online 2023 Mar 29. doi: 10.3389/fendo.2023.1093332

PMCID:: PMC10090553

Article PDF–6.4M

Select item 98909314.

Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer

Eric Feng, Nicholas R. Rydzewski, Meng Zhang, Arian Lundberg, Matthew Bootsma, Kyle T. Helzer, Joshua M. Lang, Rahul Aggarwal, Eric J. Small, David A. Quigley, Martin Sjöström, Shuang G. Zhao

Clin Cancer Res. Author manuscript; available in PMC 2023 Jun 15.

Published in final edited form as: Clin Cancer Res. 2022 Dec 15; 28(24): 5396–5404. doi: 10.1158/1078-0432.CCR-22-2567

PMCID:: PMC9890931

Article PDF–1.4M

Select item 98471205.

FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma

Ugo Chianese, Chiara Papulino, Ahmad Ali, Fortunato Ciardiello, Salvatore Cappabianca, Lucia Altucci, Vincenzo Carafa, Rosaria Benedetti

J Transl Med. 2023; 21: 32. Published online 2023 Jan 17. doi: 10.1186/s12967-023-03874-5

PMCID:: PMC9847120

Article PDF–3.0M

Select item 93113166.

Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines

Michal Hensler, Jana Rakova, Lenka Kasikova, Tereza Lanickova, Josef Pasulka, Peter Holicek, Marek Hraska, Tereza Hrnciarova, Pavla Kadlecova, Andreu Schoenenberger, Klara Sochorova, Daniela Rozkova, Ludek Sojka, Jana Drozenova, Jan Laco, Rudolf Horvath, Michal Podrazil, Guo Hongyan, Tomas Brtnicky, Michal J. Halaska, Lukas Rob, Ales Ryska, An Coosemans, Ignace Vergote, Abhishek D. Garg, David Cibula, Jirina Bartunkova, Radek Spisek, Jitka Fucikova

Oncoimmunology. 2022; 11(1): 2101596. Published online 2022 Jul 22. doi: 10.1080/2162402X.2022.2101596

PMCID:: PMC9311316

Article PDF–4.2M

Select item 92847877.

The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma

Cheng-Yuan Gu, Bo Dai, Yao Zhu, Guo-Wen Lin, Hong-Kai Wang, Ding-Wei Ye, Xiao-Jian Qin

Mol Med. 2022; 28: 78. Published online 2022 Jul 14. doi: 10.1186/s10020-022-00504-6

PMCID:: PMC9284787

Article PDF–10M

Select item 92821378.

A comprehensive investigation on pan-cancer impacts of constitutive centromere associated network gene family by integrating multi-omics data: A CONSORT-compliant article

Huimei Su, Yuchun Fan, Zhuan Wang, Lihe Jiang

Medicine (Baltimore) 2022 Feb 18; 101(7): e28821. Published online 2022 Feb 18. doi: 10.1097/MD.0000000000028821

PMCID:: PMC9282137

Article PDF–2.0M

Select item 92766329.

Changes in Lipid Profile and SOX-2 Expression in RM-1 Cells after Co-Culture with Preimplantation Embryos or with Deproteinated Blastocyst Extracts

Nicolás M. Morato, Judy E. Hallett, Wen-Hung Wang, Bennett D. Elzey, Gregory M. Cresswell, Bruce R. Cooper, Christina R. Ferreira

Mol Omics. Author manuscript; available in PMC 2023 Jul 11.

Published in final edited form as: Mol Omics. 2022 Jul 11; 18(6): 480–489. Published online 2022 Jul 11. doi: 10.1039/d2mo00071g

PMCID:: PMC9276632

Article PDF–1.2M

Select item 921354410.

Detection and characterization of latency stage of EBV and histopathological analysis of prostatic adenocarcinoma tissues

Khalid Ahmed, Alisalman Sheikh, Saira Fatima, Ghulam Haider, Kulsoom Ghias, Farhat Abbas, Nouman Mughal, Syed Hani Abidi

Sci Rep. 2022; 12: 10399. Published online 2022 Jun 21. doi: 10.1038/s41598-022-14511-4

PMCID:: PMC9213544

Article PDF–1.7M

Select item 914851311.

Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort

Benjamin D. Leibowitz, Bonnie V. Dougherty, Joshua S. K. Bell, Joshuah Kapilivsky, Jackson Michuda, Andrew J. Sedgewick, Wesley A. Munson, Tushar A. Chandra, Jonathan R. Dry, Nike Beaubier, Catherine Igartua, Timothy Taxter

BMC Cancer. 2022; 22: 587. Published online 2022 May 28. doi: 10.1186/s12885-022-09669-z

PMCID:: PMC9148513

Article PDF–5.7M

Select item 880644312.

Zinc finger C3H1 domain-containing protein (ZFC3H1) evaluates the prognosis and treatment of prostate adenocarcinoma (PRAD): A study based on TCGA data

Hang Huang, Haokai Xu, Ping Li, Xueting Ye, Wei Chen, Wei Chen, Xixi Huang

Bioengineered. 2021; 12(1): 5504–5515. Published online 2021 Sep 13. doi: 10.1080/21655979.2021.1965442

PMCID:: PMC8806443

Article PDF–2.4M

Select item 878370913.

Identification of Novel Diagnostic Biomarkers in Prostate Adenocarcinoma Based on the Stromal-Immune Score and Analysis of the WGCNA and ceRNA Network

Tengfei Zhang, Yaxuan Wang, Yiming Dong, Lei Liu, Yikai Han, Huanrong Wang, Qian Wei, Peige Xia, Wang Ma, Lifeng Li

Dis Markers. 2022; 2022: 1909196. Published online 2022 Jan 15. doi: 10.1155/2022/1909196

PMCID:: PMC8783709

Article PDF–4.8M

Select item 861676114.

Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype

Hyunho Han, Hyung Ho Lee, Kwibok Choi, Young Jun Moon, Ji Eun Heo, Won Sik Ham, Won Sik Jang, Koon Ho Rha, Nam Hoon Cho, Filippo G. Giancotti, Young-Deuk Choi

Prostate Cancer Prostatic Dis. 2021; 24(4): 1080–1092. Published online 2021 Apr 26. doi: 10.1038/s41391-021-00364-x

PMCID:: PMC8616761

Article PDF–1.9M

Select item 857180815.

Epigenetically Silenced Candidate Tumor Suppressor Genes in Prostate Cancer: Identified by Modeling Methylation Stratification and Applied to Progression Prediction

Wensheng Zhang, Erik K. Flemington, Hong-Wen Deng, Kun Zhang

Cancer Epidemiol Biomarkers Prev. Author manuscript; available in PMC 2021 Nov 6.

Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Jan; 28(1): 198–207. Published online 2018 Sep 27. doi: 10.1158/1055-9965.EPI-18-0491

PMCID:: PMC8571808

Article PDF–2.3M

Select item 850383816.

Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer

Cuijian Zhang, Jinqin Qian, Yucai Wu, Zhenpeng Zhu, Wei Yu, Yanqing Gong, Xuesong Li, Zhisong He, Liqun Zhou

Pathol Oncol Res. 2021; 27: 1609968. Published online 2021 Sep 27. doi: 10.3389/pore.2021.1609968

PMCID:: PMC8503838

Article PDF–4.5M

Select item 847594517.

Adipocyte-driven unfolded protein response is a shared transcriptomic signature of metastatic prostate carcinoma cells

Mackenzie K. Herroon, Shane Mecca, Alex Haimbaugh, Laimar C. Garmo, Erandi Rajagurubandara, Sokol V. Todi, Tracie R. Baker, Izabela Podgorski

Biochim Biophys Acta Mol Cell Res. Author manuscript; available in PMC 2022 Oct 1.

Published in final edited form as: Biochim Biophys Acta Mol Cell Res. 2021 Oct; 1868(11): 119101. Published online 2021 Jul 16. doi: 10.1016/j.bbamcr.2021.119101

PMCID:: PMC8475945

Article PDF–2.3M

Select item 833583618.

Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications

Zehua Ma, Xiankui Cheng, Ting Yue, Xun Shangguan, Zhixiang Xin, Weiwei Zhang, Jiahua Pan, Qi Wang, Wei Xue

Cancer Med. 2021 Aug; 10(15): 5358–5374. Published online 2021 Jun 15. doi: 10.1002/cam4.4063

PMCID:: PMC8335836

Article PDF–1.9M

Select item 832565619.

Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro

Richard C. Zieren, Liang Dong, David J. Clark, Morgan D. Kuczler, Kengo Horie, Leandro Ferreira Moreno, Tung-Shing M. Lih, Michael Schnaubelt, Louis Vermeulen, Hui Zhang, Theo M. de Reijke, Kenneth J. Pienta, Sarah R. Amend

Med Oncol. 2021; 38(9): 105. Published online 2021 Jul 31. doi: 10.1007/s12032-021-01554-2

PMCID:: PMC8325656

Article PDF–1.1M

Select item 828974320.

Therapy Considerations in Neuroendocrine Prostate Cancer: What Next?

Himisha Beltran, Francesca Demichelis

Endocr Relat Cancer. Author manuscript; available in PMC 2022 Jul 15.

Published in final edited form as: Endocr Relat Cancer. 2021 Jul 15; 28(8): T67–T78. Published online 2021 Jul 15. doi: 10.1530/ERC-21-0140

PMCID:: PMC8289743

Article PDF–629K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 148

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity